注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Midatech Pharma PLC是一家總部位於英國的藥物輸送技術公司。該公司專注於改善藥物的生物遞送和生物分配。該公司的技術包括Q-Sphera、MidaSolve和MidaCore。 Q-Sphera 技術專注於使用三維(3D)打印技術的長效注射劑。MidaCore技術平台使用超小金納米顆粒(GNP)藥物偶聯物。 MidaSolve Nano Inclusion技術可溶解在氫(pH)生物勢下具有最小溶解度的分子,從而擴展可用的給藥途徑,包括直接向腫瘤給藥。它擁有大約 10 個早期項目的管道,其中包括 MTD211(精神分裂症,MDD)、MTD219(預防、移植排斥)、MTX223、MTX213、MTX214、MTX110(膠質母細胞瘤)、MTX110(兒童腦癌(DIPG)),MTX110(成神經管細胞瘤)和MTX114(銀屑病)。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Daniel McCurdy | 65 | - | Member of Scientific Advisory Board |
Sijmen de Vries | 63 | 2004 | Independent Non-Executive Director |
Simon Turton | 54 | 2014 | Senior Independent Non-Executive Director |
Michael J. Natan | - | - | Member of Scientific Advisory Board |
Francesco Stellaci | - | - | Chairman of Scientific Advisory Board |
Jean-Christophe Le Roux | - | - | Member of Scientific Advisory Board |
Silke Krol | - | - | Member of Scientific Advisory Board |
David Male | - | - | Member of Scientific Advisory Board |
Soledad Penades | - | - | Member of Scientific Advisory Board |
Lorraine O'Driscoll | - | - | Member of Scientific Advisory Board |
Stephen A. Stamp | 60 | 2019 | CEO, CFO, Company Secretary & Director |
Stephen Barry Parker | 65 | 2022 | Independent Non-Executive Chairman |
Ann Merchant | 58 | 2023 | Non-Executive Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核